AFCAGRO

AFC Agro Biotech Ltd. · Pharmaceuticals and Chemicals · Cat Z

21/100

Weak

৳7.20 Non-operational

DSE Hexagon

Stands out for trades below its estimated worth, held back by little dividend.

Six lenses, each scored 0–100 from the analysis. Integrity is DSE-specific — it reads how organic the price action is (high = clean, low = concentrated-operator risk). Descriptive only, not a recommendation.

Risks & rewards

Risks (5)

⚠ Not actively trading or flagged non-operational
⚠ Z-category — higher default/governance risk
⚠ Signs of concentrated-operator price activity
⚠ Earnings trending down
⚠ Financial health deteriorating

Rewards (1)

✓ Trades below estimated fair value

Score breakdown

Price history & performance

52-week high৳8.70

52-week low৳4.10

From 52w high-17.2%

Beta1.54

7D -13.3%

1M +0.0%

3M +0.0%

6M +41.2%

1Y -10.0%

YTD +38.5%

Shareholder returns vs DSEX

AFCAGRO-7.7%

DSEX+2.4%

AFCAGRO underperformed the DSEX since Jul 8, 2026 — that's when we started tracking the index, so this window will get longer over time.

Volatility

Annualized volatility46.0%

Daily VaR (95%)-4.29%

Max drawdown (5y)-89.2%

Correlation to market0.6

Typical volatility for a DSE stock. Descriptive only — past volatility is not a forecast.

Technical read

RSI (14)40.3

MACDbearish

Bollingerbelow lower band

Price cycle (Wyckoff)

Health trenddeteriorating

Flow pressureaccumulation

Valuation

Fair value ()

Upside—

Dividend yield+0.60%

Fundamental verdictSUSTAINABLE

Confidence—

Ownership

Institutional holding34.11%

Foreign holding0.0%

Free float38.05%

Sponsor, institutional, foreign and public holdings from the latest disclosed shareholding pattern. Descriptive only.

Share structure

Authorized capital৳3,000mn

Paid-up capital৳1,152.16mn

Face value৳10

Market lot1

Outstanding shares115,216,200

Last AGM29-12-2022

Fiscal year end30-Jun

Reserve & surplus (ex-OCI)৳943.6mn

Other comprehensive income৳0.2mn

Financials

Recent P/E ratio

DateCurrent P/ETrailing P/E

Jul 14, 2026 32.21 —

Jul 13, 2026 31.76 —

Jul 12, 2026 31.76 —

Jul 9, 2026 34.85 —

Jul 8, 2026 34.41 —

Jul 7, 2026 34.41 —

Based on the latest un-audited financial statements. Descriptive only.

Dividend history

20220.5%

20210.5%

Earnings & NAV

YearEPSNAVDividend

2022 0.22 18.19 0.5%

2021 0.15 18 0.5%

2020 0.32 17.85 0%

2019 3.22 19.29 0%

Quarterly EPS — FY2023

Q10.15

Q20.02

Half-year0.16

Q30.01

Nine-month0.17

From disclosed annual reports and dividend declarations. Descriptive only, not a forecast.

Levels

Resistance

৳7.3

৳7.7

৳8.2

৳8.5

Support

৳7.1

৳6.8

৳6.5

৳6.3

Historical bounce zones

Dec 8, 2025: ৳4.8→৳6.1 +27%

Dec 18, 2025: ৳4.6→৳5.5 +20%

Dec 29, 2025: ৳4.9→৳5.7 +16%

Jan 14, 2026: ৳4.7→৳7.5 +60%

Feb 19, 2026: ৳6.5→৳7.5 +15%

Mar 9, 2026: ৳6.3→৳8.2 +30%

May 24, 2026: ৳6.8→৳8.2 +21%

Jun 9, 2026: ৳7.1→৳8.3 +17%

Sector peers

Other Pharmaceuticals and Chemicals names, ranked by our analysis score (DSE has no market-cap feed). Descriptive comparison only.

ScripScorePriceUpsideYield

IBNSINAThe IBN SINA Pharmaceutical Industry PLC 87 ৳326.5 +12.00% +2.00%MARICOMarico Bangladesh Limited 87 ৳2,732.4 +24.00% +2.20%SQURPHARMASquare Pharmaceuticals PLC. 85 ৳221.4 +120.00% +5.40%ACMELABThe ACME Laboratories Limited 79 ৳86.9 +138.00% +4.10%BXPHARMABeximco Pharmaceuticals PLC. 78 ৳153.2 +54.00% +2.60%RENATARenata PLC 64 ৳464.3 -25.00% +1.20%

Historical outlook

Based on how similar setups behaved historically — not a prediction of what will happen.

10-day 48% vs 40% market avg Typical move: -4.5% / -0.3% / 4.5%

30-day 41% vs 42% market avg Typical move: -7.9% / -0.9% / 7.4%

Signals: Below lower Bollinger|Bullish Harami

Reference levels

Descriptive reference points from the analysis — not instructions to buy or sell.

Entry readSLEEVE only ≈7.2 (or dip 7.8)

Reference stopclose<7.8 (raw, tight)

Reference target⅓ at 7.2, trail rest

Timing notesleeve; enter Nov-Jan; OUT by Jun/Sep

strong artificial activity (score 284); speculative profile — not core-quality. Phase: ACCUMULATION (10% >200-MA, flow ACC) -> accumulation phase. Z-cat. HIGH-BETA 1.54 — amplifies market ~1.54x (drawdown risk in a downturn). ⚠ Balance sheet DETERIORATING (Altman Z falling) — early warning. ⚠ PAPER-PROFIT — reports profit but NEGATIVE cash flow (accrual red flag; earnings not real cash). [fundamentals SUSTAINABLE, payout 23.0%, yield 0.6%]